CalciMedica, Inc. — Form 8-K
Filed October 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
CalciMedica filed an 8-K on 2026-10-16 reporting Item 5.02 (departure of directors/officers and compensatory arrangements). The filing does not provide the specific names of departing officers, dollar amounts of compensation, equity details, severance terms, or effective dates in the metadata provided. Full details would require review of the actual 8-K document content.
Why this rating
Officer departure is routine corporate event; without disclosed severance/equity details or named executive, cannot assess material impact to $15.7M market-cap company.
Extracted items
See more from October 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.